A detailed history of Findlay Park Partners LLP transactions in Illumina, Inc. stock. As of the latest transaction made, Findlay Park Partners LLP holds 716,000 shares of ILMN stock, worth $94.3 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
716,000
Previous 723,500 1.04%
Holding current value
$94.3 Million
Previous $75.5 Million 23.63%
% of portfolio
0.96%
Previous 0.76%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$105.28 - $135.9 $789,600 - $1.02 Million
-7,500 Reduced 1.04%
716,000 $93.4 Million
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $565,880 - $747,992
-5,600 Reduced 0.77%
723,500 $75.5 Million
Q1 2024

Apr 30, 2024

BUY
$127.73 - $147.2 $93.1 Million - $107 Million
729,100 New
729,100 $100 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Findlay Park Partners LLP Portfolio

Follow Findlay Park Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Findlay Park Partners LLP with notifications on news.